The drug discovery process.
Herrling
Paul L
PL
Novartis International AG, Corporate Research, CH-4002 Basel, Switzerland. paul.herrling@novartis.com
D000818:Animals; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D006801:Humans; D013678:Technology, Pharmaceutical